KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aurinia Pharmaceuticals (AUPH) Depreciation & Amortization (CF) (2020 - 2025)

Historic Depreciation & Amortization (CF) for Aurinia Pharmaceuticals (AUPH) over the last 10 years, with Q3 2025 value amounting to $4.9 million.

  • Aurinia Pharmaceuticals' Depreciation & Amortization (CF) fell 57.22% to $4.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $19.4 million, marking a year-over-year increase of 12919.27%. This contributed to the annual value of $19.4 million for FY2024, which is 6695.29% up from last year.
  • As of Q3 2025, Aurinia Pharmaceuticals' Depreciation & Amortization (CF) stood at $4.9 million, which was down 57.22% from $4.9 million recorded in Q2 2025.
  • Aurinia Pharmaceuticals' 5-year Depreciation & Amortization (CF) high stood at $5.3 million for Q3 2023, and its period low was -$6.1 million during Q4 2023.
  • Its 5-year average for Depreciation & Amortization (CF) is $1.8 million, with a median of $719000.0 in 2023.
  • Its Depreciation & Amortization (CF) has fluctuated over the past 5 years, first skyrocketed by 563333.33% in 2021, then plummeted by 22315.85% in 2023.
  • Quarter analysis of 5 years shows Aurinia Pharmaceuticals' Depreciation & Amortization (CF) stood at -$1.4 million in 2021, then tumbled by 38.04% to -$1.9 million in 2022, then tumbled by 223.16% to -$6.1 million in 2023, then skyrocketed by 179.73% to $4.9 million in 2024, then rose by 0.06% to $4.9 million in 2025.
  • Its Depreciation & Amortization (CF) stands at $4.9 million for Q3 2025, versus $4.9 million for Q2 2025 and $4.9 million for Q1 2025.